Center for Genetic Engineering and Biotechnology (CIGB): CIGB-66

Vaccine Type: Protein Subunit

This vaccine may also be referred to as Abdala

Vaccine Trial & Approval Tracker

This vaccine has reached Phase 3 trials.

About Trial Phases

Phase 1: 2 Trials

Phase 2: 2 Trials

Phase 3: 1 Trial


This vaccine is not yet approved.

Registered Trials